Difference between revisions of "Team:Exeter/Awards"
| Line 884: | Line 884: | ||
was discussed and designed parts to address the major concerns.</li> | was discussed and designed parts to address the major concerns.</li> | ||
<br /><li>Outreach integration - | <br /><li>Outreach integration - | ||
| − | <ul> | + | <ul style="font-size:100%;"> |
<li>We took a different approach to integrated Human Practices by integrating the Equality and Diversity work into itself - each interview influenced the next forming a | <li>We took a different approach to integrated Human Practices by integrating the Equality and Diversity work into itself - each interview influenced the next forming a | ||
grounded analysis of the issue.</li> | grounded analysis of the issue.</li> | ||
| Line 893: | Line 893: | ||
</ul> | </ul> | ||
<h6>Improve a previous part or project:</h6> | <h6>Improve a previous part or project:</h6> | ||
| − | <ul> | + | <ul > |
<li>We have further characterised KillerRed by testing it under a wider range of conditions and quantified the length of time for it to remain viable as a kill switch.</li> | <li>We have further characterised KillerRed by testing it under a wider range of conditions and quantified the length of time for it to remain viable as a kill switch.</li> | ||
<br /><li>We have improved Lysozyme C by adding a signal peptide targeting it to the periplasm where it is most effective.</li> | <br /><li>We have improved Lysozyme C by adding a signal peptide targeting it to the periplasm where it is most effective.</li> | ||
Revision as of 01:02, 20 October 2016
